BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23912049)

  • 1. Effects of endostar combined multidrug chemotherapy in osteosarcoma.
    Xu M; Xu CX; Bi WZ; Song ZG; Jia JP; Chai W; Zhang LH; Wang Y
    Bone; 2013 Nov; 57(1):111-5. PubMed ID: 23912049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.
    Rossi B; Schinzari G; Maccauro G; Scaramuzzo L; Signorelli D; Rosa MA; Fabbriciani C; Carlo B
    BMC Musculoskelet Disord; 2010 Feb; 11():34. PubMed ID: 20158913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin.
    Kaya M; Wada T; Nagoya S; Yamashita T
    J Orthop Sci; 2007 Nov; 12(6):562-7. PubMed ID: 18040639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic factor endostatin in osteosarcoma.
    Kim HS; Lim SJ; Park YK
    APMIS; 2009 Oct; 117(10):716-23. PubMed ID: 19775339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the role of angiogenesis and related factors in leukemias].
    Zhang Y; Gu J; Wang M; Ma L; Wang XL; He B; Sun M
    Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):175-8. PubMed ID: 15946533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endostar combined with chemotherapy for treatment of metastatic colorectal and gastric cancer: a pilot study.
    Zhou JF; Bai CM; Wang YZ; Li XY; Cheng YJ; Chen SC
    Chin Med J (Engl); 2011 Dec; 124(24):4299-303. PubMed ID: 22340403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic treatment with endostatin inhibits progression of AML in vivo.
    Schuch G; Oliveira-Ferrer L; Loges S; Laack E; Bokemeyer C; Hossfeld DK; Fiedler W; Ergun S
    Leukemia; 2005 Aug; 19(8):1312-7. PubMed ID: 15931265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive imaging surrogate of angiogenesis in osteosarcoma.
    Bajpai J; Gamanagatti S; Sharma MC; Kumar R; Vishnubhatla S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
    Pediatr Blood Cancer; 2010 Apr; 54(4):526-31. PubMed ID: 19890899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endostatin in different administration routes combined with adriamycin chemotherapy in the treatment of liver cancer xenograft in mice].
    Wang ZX; Wang SM; Zhou Q; Hu XG; Zhu WL; Meng H; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1903-5. PubMed ID: 20813697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
    Ek ET; Ojaimi J; Kitagawa Y; Choong PF
    Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of primary tumor excision on angiogenesis and pulmonary metastasis in osteosarcoma-bearing nude mice].
    Mei J; Ni M; Chen YX; Yao B; Gao YS; Yu XM; Wang ZY
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):246-9. PubMed ID: 19615274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human endostatin, Endostar, enhances the effects of chemo-radiotherapy in a mouse cervical cancer xenograft model.
    Jia Y; Liu M; Cao L; Zhao X; Wu J; Lu F; Li Y; He Y; Ren S; Ju Y; Wang Y; Li Z
    Eur J Gynaecol Oncol; 2011; 32(3):316-24. PubMed ID: 21797125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F
    Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of increased angiogenesis in osteosarcoma.
    Kreuter M; Bieker R; Bielack SS; Auras T; Buerger H; Gosheger G; Jurgens H; Berdel WE; Mesters RM
    Clin Cancer Res; 2004 Dec; 10(24):8531-7. PubMed ID: 15623635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered angiogenic balance in keloids: a key to therapeutic intervention.
    Mogili NS; Krishnaswamy VR; Jayaraman M; Rajaram R; Venkatraman A; Korrapati PS
    Transl Res; 2012 Mar; 159(3):182-9. PubMed ID: 22340768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic study on effect of Chinese medicine compound Yiliuyin on angiogenesis in transplanted S180 tumor of mouse].
    Han Z; Wang R; Li T; Yang Z; Cui C; Ding J; Zhang Z; Deng Y; Wang P
    Zhongguo Zhong Yao Za Zhi; 2009 Jan; 34(2):212-6. PubMed ID: 19385189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
    Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
    Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictive value of serum angiogenic factor in patients with osteosarcoma.
    Chen Z; Chen QX; Hou ZY; Hu J; Cao YG
    Asian Pac J Cancer Prev; 2012; 13(9):4823-6. PubMed ID: 23167426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human endostatin antiangiogenic gene therapy mediated by recombinant adeno-associated virus vector in nude mouse with endometriosis].
    Sun JJ; Yin LR; Mi RR; Ma HD; Guo SJ; Shi Y; Gu YJ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):45-50. PubMed ID: 20367926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.